About Longevity Clinics & Platforms
The Longevity Clinics & Platforms category is part of the Longevity & Human Enhancement market map, tracking 13 companies building in this segment. Senolytics, epigenetic reprogramming, exoskeletons, nootropics, and implantable devices pushing the boundaries of human lifespan and performance. Curated by Hartmann Capital's venture research team.
Companies in Longevity Clinics & Platforms
- AgelessRx — Pre-Seed, $1M
- Numan — Series B, $60M
- Midi Health — Series C, $100M
- Hevolution Foundation — Non-Profit
- Fountain Life — Series A, $30M
- Oura — Series D, $200M
- Ultrahuman — Series B, $55M
- Whoop — Series F, $400M
- Levels — Series A, $50M
- Thorne HealthTech — Public
- Longevity Copilot
- Healthspan — Seed, $3M
- Wild Health — Series A, $15M
Frequently Asked Questions
- What companies are in the Longevity Clinics & Platforms category?
- The Longevity Clinics & Platforms category includes 13 companies: AgelessRx, Numan, Midi Health, Hevolution Foundation, Fountain Life, Oura, Ultrahuman, Whoop, Levels, Thorne HealthTech, Longevity Copilot, Healthspan, Wild Health. This is part of the Longevity & Human Enhancement market map maintained by Hartmann Capital.
- How many Longevity Clinics & Platforms startups are tracked?
- Hartmann Capital tracks 13 companies in the Longevity Clinics & Platforms segment of the Longevity & Human Enhancement market map.
- What are the best funded Longevity Clinics & Platforms companies?
- Top funded companies in Longevity Clinics & Platforms include Whoop ($400M), Oura ($200M), Midi Health ($100M), Numan ($60M), Ultrahuman ($55M). Browse the full list in the Longevity & Human Enhancement market map.
- How can I submit my startup?
- You can submit your startup for inclusion by visiting the submission page. Submissions are reviewed by Hartmann Capital's research team.